Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 27, 2015 (11 years ago)

Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Polyethylene Glycol 3350-GRX Powder 100% jars a) 8.4 oz (250 g) (NDC 54162-335-02), b) Net wt. 16.9 oz (500 g) (NDC 54162-335-05), Distributed by: Geritrex Corporation, Mount Vernon, NY 10550

Affected NDCs 54162-0335-02 54162-0335-05

Compare with the code on your package — it is the most precise check available.

Recalling firm
Geritrex Corp
NDC code
54162-335-02
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0393-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Geritrex Corp

All 2015 recalls

Other unapproved drug recalls from 2015

All unapproved drug recalls
Class II · Moderate risk

GRx HiCort 25

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-015-12 D-0392-2016
Class II · Moderate risk

Carbo-O-Philic 40 Gel 40%

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-016-15 D-0391-2016
Class II · Moderate risk

Carbo-O-Philic 40 Cream 40%

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-640-03 D-0390-2016
Class I · High risk

Xcellerator

Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.

Terminated Unapproved drug Novacare, LLC D-0973-2016